[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"transdiagnostic-psychopathology\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:transdiagnostic-psychopathology":31},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,67],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":33,"overallStatus":55,"whyStopped":4,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":64,"locationsCount":5},"100626273","blue-blocking-glasses-for-sleep-disorders-in-child-and-adolescent-psychiatry-100626273",false,"NCT07433491","Blue-blocking Glasses for Sleep Disorders in Child and Adolescent Psychiatry","Blue-blocking Glasses for Treating Evening Activation and Sleep Disorders in Child and Adolescent Psychiatry - a Pilot Trans-diagnostic Randomized Controlled Trial.","BATCAT-pilot","Inclusion Criteria:\n\n* Age 12-18 years, receiving health-care from child and adolescent mental health services at UPA University Hospital of North Norway, Tromsø or BUP Haugesund Hospital, Haugesund\n* Current Insomnia or DSPD comorbid to one or several pychiatric symptom presentations or diagnoses\n* Able and willing to provide written informed consent\n* Participants aged 12-15,9 years also need consent from both parents\u002Fcarers\n* Able to comply with protocol\n* Able to discontinue melatonin or BB-glasses if currently used, with at least 3 days washout period\n\nExclusion Criteria:\n\n* Not able to comply with protocol for a required minimum of one night\n* Blindness or severely reduced translucency of both eyes\n* Known malformation or damage of optical tract blindness\n* Use of melatonin all formulas that cannot be paused\n* High risk for suicide or self-harm\n* Consent from both partents\u002Fcarers unlikely (participants age 12-15,9 years)","ALL","12 Years","18 Years",{"count":21,"type":22},40,"ESTIMATED","INTERVENTIONAL",[25],"NA","Sleep problems and regulation difficulties are frequent in the child and adolescent psychiatry population. Insomnia and delayed sleep-wake phase disorders (DSPWD) are highly prevalent, and risk factors for developing more severe illness courses and chronic disorders. Pharmacological treatments of sleep disorders dominate even for the youngest patients but are unsupported by long-term data on outcome and side effects. The majority of non-pharmacological treatment options are composite and resource demanding. The investigators will examine the effects and feasibility of the isolated intervention of evening\u002Fnight use of blue-blocking glasses\u002Freal darkness as adjunctive treatment for insomnia and delayed sleep phase disorder in inpatient and outpatient settings for children and adolecents.",[28,29,30,31,32],"Insomnia","Delayed Sleep Phase Disorder","Hyperarousal","Transdiagnostic Psychopathology","Child and Adolescent Psychiatry",[34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54],"children","adolescents","child and adolescent psychiatry","insomnia","delayed sleep phase disorder","hyperarousal","sleep","hospital ward","outpatients","Blue-blocking glasses","virtual dark therapy","blue-blocking interventention","mobile-phone","screen","actigraphy","6-sulfatoxymelatonin","Heart Rate Variability","light","activation","melatonin","inpatients","NOT_YET_RECRUITING","2026-02-24",{"date":58,"type":59},"2026-02-25","ACTUAL",{"date":61,"type":22},"2026-02-01",{"date":63,"type":22},"2027-06-01",{"name":65,"class":66},"Helse Fonna","OTHER",{"id":68,"slug":69,"hasResults":11,"nctId":70,"briefTitle":71,"officialTitle":72,"acronym":73,"eligibilityCriteria":74,"healthyVolunteers":75,"sex":17,"minAge":19,"maxAge":76,"enrollmentInfo":77,"targetDuration":4,"studyType":23,"phases":79,"briefSummary":80,"conditions":81,"keywords":86,"overallStatus":55,"whyStopped":4,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":96,"completionDateStruct":98,"leadSponsor":100,"locationsCount":102},"100584010","digital-rewards-and-retention-in-a-m-health-app-100584010","NCT06883773","Digital Rewards and Retention in a M-health App","Does Engagement in a Computerized M-Health Intervention Increase With Digital Rewards?","DIGITALRCT","Inclusion Criteria:\n\n* English speaking\n\nExclusion Criteria:\n\n\\-",true,"60 Years",{"count":78,"type":22},177,[25],"Attrition and user engagement are two challenges that eHealth interventions struggle with. Attempts to address this have been previously made through gamification, instructional design and using different types of incentives. Overall, any type of reward, be it non-financial or monetary is better than the controls, but the latter usually produce a greater effect. It is also worth mentioning that having an affective value attached to the reward itself is also important to user retention and engagement. Given the ever-increasing interest in cryptocurrency and its current relevance, the present study - a randomized clinical trial with three arms - aims to compare cryptocurrency to non-monetary rewards regarding their effectiveness in reducing attrition and increasing engagement. In order to do this, a mental-health computerized intervention will be developed, in which the users will have to complete several modules, during which time they will be rewarded either with cryptocurrency, sweepstake rewards (e.g., vouchers), or nothing.",[31,82,83,84,85],"Attrition","Engagement","Depression, Anxiety","Stress",[87,88,89,90,91,92],"crypto","digital rewards","mHealth","attrition","CBT","NFT","2025-03-12",{"date":95,"type":59},"2025-03-19",{"date":97,"type":22},"2025-03-15",{"date":99,"type":22},"2025-09-01",{"name":101,"class":66},"University of Bucharest",1]